Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis

Amyloid. 2017 Mar;24(sup1):58-59. doi: 10.1080/13506129.2017.1292900.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Letter

MeSH terms

  • Adult
  • Aged
  • Amyloid / immunology*
  • Antibodies, Monoclonal / therapeutic use*
  • Drug Resistance
  • Female
  • Humans
  • Immunoglobulin Light-chain Amyloidosis / drug therapy*
  • Immunoglobulin Light-chain Amyloidosis / pathology
  • Male
  • Middle Aged
  • Prognosis
  • Recurrence
  • Salvage Therapy*

Substances

  • Amyloid
  • Antibodies, Monoclonal
  • monoclonal antibody 11-1f4